Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019

IMPORTANCE: Children of all ages appear susceptible to severe acute respiratory syndrome coronavirus 2 infection. To support pediatric clinical studies for investigational treatments of coronavirus disease 2019 (COVID-19), pediatric-specific dosing is required. OBJECTIVE: To define pediatric-specifi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Pediatr
Hlavní autoři: Maharaj, Anil R., Wu, Huali, Hornik, Christoph P., Balevic, Stephen J., Hornik, Chi D., Smith, P. Brian, Gonzalez, Daniel, Zimmerman, Kanecia O., Benjamin, Daniel K., Cohen-Wolkowiez, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2020
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7275264/
https://ncbi.nlm.nih.gov/pubmed/32501511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.2422
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky